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Background: Collagen acts as a scaffold for healing damaged cartilage. This study evaluated the results of an
in vivo animal study and provides short-term clinical results on a mixture of atelocollagen and fibrin glue-enhanced
microfracture techniques in patients with osteochondral lesions (OCL) of the talus.
Methods: This paper contains animal in vivo data and clinical outcomes on the effectiveness of atelocollagen. An
in vivo animal study was conducted with full-thickness cartilage defects created in the femoral condyle of 12 rabbits
equally divided into 4 groups evaluated at 2, 4, 8, and 12 weeks. Four chondral lesions were created according to
one procedure on each rabbit with each lesion treated as follows: (1) microfracture, (2) microfracture and the lesion
covered with atelocollagen, (3) microfracture and the lesion covered with mixture of atelocollagen and fibrin glue,
and (4) microfracture and the lesion covered with fibrin glue. In the clinical evaluation, 17 patients were treated
with a combination of microfracture and atelocollagen injection for symptomatic full-thickness OCL of the talus.
They were evaluated by the American Orthopedic Foot and Ankle Society Ankle-Hindfoot Score (AOFAS), Hannover
Ankle Score System (HSS), visual analog scale (VAS), and magnetic resonance imaging (MRI) at baseline and at 12-months
follow-up. Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) score of the post-op status was
compared with the MOCART score and a modified Anderson’s score of the pre-op status.
Results: In the animal study, subchondral bone and cartilage were generated completely in groups 2 and 3
microscopically. Hyaline-like cartilage was found in the repair tissue. In the clinical evaluation, mean AOFAS improved from
62 to 88, mean HSS improved from 62 to 87, and mean VAS score improved from 64 to 18, respectively (p <0.001). Fifteen
patients (89 %) reported good or excellent satisfaction. We defined the improvement of most of the subchondral bone
edema and bone cyst as well as a chondral lesion by radiologic evaluation.
Conclusions: Rapid regeneration of cartilage was demonstrated in the in vivo animal study, and patients showed
significant clinical improvement. Atelocollagen-enhanced microfracture enabled a reasonable treatment of
cartilage defects.
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Traumatic and degenerative cartilage injury occurs fre-
quently in knee and ankle joints; however osteochondral
lesions receive more attention due to their correlation
with the progression of joint degeneration [1]. Adult car-
tilage has very low intrinsic activity and low potential for
regeneration. Cell migration does not occur due to low
vascularity and high stiffness. Consequently, the histo-
logical characteristics of cartilage that cannot form cell
clumps lead to a lack of essential cells and collagen that
is unable to recruit local sources of progenitor cells at
the articular surface as well as the synovial lining of the
joint cavity [2]. Therefore, healing of chondral and
osteochondral defects may not be expected. Microfrac-
ture, osteochondral autologous transplantation (OATS),
and ACI are the most well-known treatments for these
injuries [3]. Especially, microfracture is widely used and
induces the repair of localized articular cartilage defects
of the talus with encouraging mid-term and long-term
follow-up results [4, 5]. However, microfracture has sev-
eral limitations. First, fibrin clot is not mechanically
stable enough to withstand tangential forces [6] and is
also easily washed out by synovial fluid. Second, they are
damaged by axial forces, and the regeneration abilities of
the chondrocytes may disappear. Last, damaged parts
are filled with fibrous cartilage instead of hyaline-like
cartilage. Fibrin glue and biomembrane, types of colla-
gen, were developed as a scaffold due to the slight ad-
vantage of microfracture and for compensating stability.
As described by Gille et al., an implanted exogenous
scaffold (e.g., collagen matrix) may improve mechanical
stability; in addition, the durability of cellular environ-
ment proved beneficial for the chondrogenic differenti-
ation and cartilage regeneration [7, 8].
Collagen is often used as a scaffold during cartilage re-
generation. Collagen-gels have been used for in vitro
and in vivo cartilage-regeneration experiments [9, 10],
with some applied to clinical cases [11, 12]. CartiFill™
(atelocollagen, Sewon Cellontech, Seoul, Korea) is an
atelocollagen that satisfies the scaffold criteria and repre-
sents an initial structural protein made from osteocytes
during the bony healing process. Atelocollagen exhibits
an ideal biocompatibility due to reduced antigenicity
from the removal of telopeptide and the structural simi-
larity of porcine collagen to human collagen versus bo-
vine collagen. It also aids in the regenerative process
through various tissue-specific biological substrates and
helps the fibro-cartilaginous complex to fix chondral de-
fect sites more firmly.
We hypothesize that atelocollagen helps regenerate
the osteochondral defect that acts as a scaffold for the
in vivo animal study and clinical outcomes. This study is
a macroscopic observation of the regeneration of articu-
lar cartilage in an in vivo animal study; in addition, itshows the efficacy of atelocollagen through an evaluation
of clinical and radiologic outcomes in preliminary clin-
ical studies.
Methods
All animal experiments were conducted according to
guidelines provided by the animal committee of the central
government (SC-IACUC-11-004). We compared the effects
of microfracture and atelocollagen-enhanced microfracture
in rabbits. Twelve mature male New Zealand white rabbits
(weight, 3.5–4.5 kg) were divided into four groups for
evaluation at 2, 4, 8, and 12 weeks. All surgeries were per-
formed under sterile conditions. Each animal was premedi-
cated according to weight with an intramuscular injection
of Zoletil (Virbac, Carros, France) and xylazine (Bayer,
Leverkusen, Germany) to obtain effective anesthesia. A
3-cm medial parapatellar incision was made over the
knee, and the patellar was everted. A full-thickness de-
fect (4 mm in diameter, 3 mm in depth) in the articular
cartilage and subchondral bone was made with an elec-
tric burr applied to the femoral condyle of the femur.
Guidelines of the American Society for Testing and
Materials (ASTM) International indicate that the crit-
ical size of a chondral defect in rabbit is 3 mm in diam-
eter [13]. Consequently, this study made four bilateral
full-thickness cylindrical osteochondral defects (4 mm
in diameter). All defects used Kirschner-wire to induce
a microfracture before the following four procedures:
(1) no treatment for control, (2) microfracture and cov-
ering of the lesion with atelocollagen, (3) microfracture
and covering of the lesion with a mixture of atelocolla-
gen and fibrin glue, and (4) microfracture and covering
of the lesion with fibrin glue (Fig. 1). Implants were
then inserted into the defect, and after reducing the pa-
tella, the capsule and muscle were closed with a double
3–0 VICRYL (Ethicon Inc., Somerville, USA) suture,
and the skin was closed with a continuous 3–0 Nylon
(AILEE, Pusan, South Korea) suture. After the oper-
ation, a splint immobilized the knee joint for 10 days.
Rabbits were maintained in small cages for 2 weeks and
allowed to move freely. Knee joints were harvested at 2,
4, 8, and 12 weeks after the operation and macroscopic-
ally assessed for surface regularity, surface area, and re-
generated tissue color. Harvested knee joints were
simultaneously fixed in 10 % phosphate-buffered for-
malin for at least 24 h at room temperature. After fix-
ation, specimens were decalcified, dehydrated, cleansed,
and embedded in paraffin. The 5-mm-thick sections of
embedded tissues were cut using a microtome and
stained with Hematoxylin-Eosin. Immunohistochemis-
try with antibodies for type-II collagen was performed
according to a standard ABC protocol (Vector Labora-
tories, Burlingame, USA). The type-II antibody was pro-
duced in-house. Specimens were graded with a modified
Fig. 1 In vivo animal study procedure. Microfracture done at the femoral condyle cartilage of a rabbit, and the lesion was covered with scaffolds.
a Microfracture done at the femoral condylar cartilage lesion of a rabbit. b Result of microfracture (chondral lesion, diameter, 4 mm; depth,
3 mm) c covered with scaffold material (fibrin glue or atelocollagen or mixture of fibrin glue and atelocollagen)
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Pineda et al. [15], and O’Driscoll et al. [16]. The scale
had seven categories that assigned a score of 0 to 23
points (lower scores represent superior cartilage regen-
eration). The clinical evaluation used a retrospective
analysis of prospectively collected clinical data from 17
patients (10 males and 7 females) treated with a com-
bination of microfracture and covering with a mixture
of atelocollagen and fibrin glue that was evaluated
and approved by the institutional review board (EMC
IRB09-08) prior to the procedure. From 1 May 2011
to 31 April 2011, we identified 52 patients with osteo-
chondral lesion of talus (OLT) who required surgical
treatment due to the failure of conservative treatments;
subsequently, we included 17 patients who agreed with
informed consent in a preliminary clinical trial. The
study included patients with osteochondral lesions of
the talus (OLT) who were in pain or had limitations
of function despite 6 months of conservative treatment
like physical therapy (hot pack, ultrasound and transcutane-
ous electrical nerve stimulation), medication (NSAIDs), and
hyaluronic acid injection every week for three times. Pa-
tients also had protected weight-bearing using orthosis and
strengthening exercises when ankle instability was ob-
served. All patients were primary cases and were asked
about general health information to exclude patients who
had diseases that could affect the healing process of the
talus, including rheumatic diseases, systematic inflamma-
tory disease, crystal-induced arthropathy, or diffuse arthritis
with at least Kellgren lawrence grade II or TAKAKURA
grade II. All lesions were checked with plain X-rays and
magnetic resonance imaging (MRI) to measure size and
diagnose associated pathology. Preoperative MRI was eval-
uated with a modified Anderson’s score [17]. A marked
probe measured the lesions during the operation. We as-
sume that collagen defects are elliptical and that the defect
size was calculated (multiplication of coronal and sagittal
length and 0.79). A surgeon diagnosed other ankle diseases
such as instability or Os subfibulare by physical examin-
ation and a radiological evaluation. Chronic ankle in-
stability and Os subfibulare occurred in ten and two cases,respectively. A modified Bröstrom procedure (a lateral liga-
ment augmentation procedure with superior extensor reti-
naculum) was conducted in four patients, arthroscopic
anterior talofibular ligament (ATFL) reconstruction was
done in six patients, and excision of Os subfibulare was
done in two patients, with plate and screw removal done
in one patient.
Clinical outcomes were measured with the following:
American Foot and Ankle Society Ankle-Hindfoot Score
(AOFAS), the Hannover Ankle Score System (HSS), and a
visual analog scale (VAS) at baseline and at 12 months. Pa-
tient satisfaction with outcomes was scored by four grades
(excellent/good/fair/poor). A post-operative follow-up MRI
was done at 12 months and classified according to a Modi-
fied Magnetic Resonance Observation of Cartilage Repair
Tissue (MOCART) score [18] and a modified Anderson’s
score.
All procedures were performed under general anesthesia
by a single experienced surgeon using an arthroscopic
technique with tourniquet. All lesions were accessible
using two standard anteromedial and anterolateral portals.
A blunt trocar with a 30° arthroscope was inserted
through the anteromedial portal into the joint. Arthro-
scopic synovectomy was done along with a careful exam-
ination of the status of the talar dome. Unstable chondral
fragments were completely excised with a curette and
shaver; additional debridement was performed if the sub-
chondral bone was weak. Fat droplets were checked after
microfractures were placed 4–5 mm apart and 4–5 mm
deep. The ankle joint was suction dried to remove intra-
articular fluid. A two-way syringe injected the mixtures
through the portal with a slow injection procedure done
under arthroscopic sight to prevent overflow. The proced-
ure made several atelocollagen layers and repeatedly
attaching layers on the prior atelocollagen layer to form a
complete seal. We waited 5 min for the atelocollagen to
harden and then closed the wound in layers, approxi-
mated the skin with absorbable subcutaneous sutures, and
applied a compressive dressing (Fig. 2). Patients were
splinted for 4 weeks before a range of motion exercises
was started with a brace. Partial weight bearing was
Fig. 2 Surgical procedure. a Microfracture was done. b Removal of the intra-articular fluid by suction and prepared talus as dry status by Endo
Peanut. c Injection of the mixture of atelocollagen and fibrin glue as a slow drip. d A 5-min wait to harden the substances
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bearing was permitted at 4 weeks. Patients were allowed
to jog 3 months after the operation and return to normal
sports activity at 6 months follow-up.
Statistical analysis
Differences between preoperative and post-operative
AOFAS, VAS, and HSS were determined using a paired
t-test. A Pearson’s correlation test statistically evaluated
the postoperative clinical score (AOFAS score, Hannover
score, and VAS score) and MOCART score. A p value
<0.05 was considered statistically significant (SPSS 16.0
for Windows, Chicago, Illinois).
Results
In vivo animal study
Most lesions in group 3 were macroscopically filled with
repair tissue at 4 weeks after operation. At 12 weeks,
lesions were completely filled with regenerated tissue in
groups 2 and 3; however, the defect was still caved with-
out repaired tissue in groups 1 and 4 (Fig. 3). A micro-
scopic view indicated that the cartilage defects were
sufficiently filled with repair tissue; in addition, regener-
ation of subchondral bone was not detected 12 weeks
post operation in groups 1 and 4. Subchondral bone and
cartilage were almost generated completely in groups 2
and 3. Group 3 indicated subchondral bone and cartilage
repair that smoothly linked with adjacent normal cartil-
age. Group 2 indicated subchondral bone repair partiallythat connected with normal cartilage on only one side of
the defect (Fig. 4). The regenerated tissues in groups 2
and 3 also reacted strongly with the collagen type-II
stain and safranin O stain. The collagen type-II stain
showed that the regenerated tissues were hyaline-like
cartilage which is histologically the same as normal car-
tilage (Fig. 5). Table 1 shows the histological scoring for
in vivo animal study. At 12 weeks, groups with atelocol-
lagen significantly improved compared to the fibrin glue
group; subsequently, the group with a mixture of atelo-
collagen and fibrin glue showed the best results.
Clinical outcome
Seventeen patients were treated with a mixture of atelo-
collagen and fibrin glue-enhanced microfracture (10
males and 7 females). The mean follow-up was 16 ±
4.2 months. No patient was lost to follow-up to check
clinical outcome; however, six patients declined to be
evaluated by MRI. Mean defect size was 71.9 ± 36.0 mm2
(range, 9.4–156.4 mm2) (Table 2). The clinical outcome of
all patients improved, and the average AOFAS score was
62 ± 12.2 (range, 36–80) before surgery and 88 ± 6.7
(range, 75–100) 12 months after implantation. The aver-
age VAS was 64 ± 12.4 mm (range, 40–85) at screening
and 18 ± 7.9 mm (range, 5–35) 12 months after implant-
ation. The average preoperative HSS score was 62 ± 9.1
(range, 51–77) and increased to 87 ± 8.7 (range, 73–96) at
the 12 month visit. The AOFAS score, VAS, and HSS
score improved significantly 12 months after implantation
Fig. 3 Macroscopic view of the repaired tissue after 2, 4, 8, and 12 weeks after implantation in the in vivo study. a Microfracture. b Microfracture +
atelocollagen. c Microfracture + atelocollagen + fibrin glue. d Microfracture + fibrin glue 2, 4, 8, and 12 weeks
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lent (53 %), six good (36 %), two fair (11 %), and none
poor (0 %) at the 12-month visit. A total of 15/17 patients
(89 %) scored satisfaction with the technique as good.
Table 3 illustrates the radiographic score of patients at
pre-operation and follow-up. Table 4 records the modified
Anderson’s score for the cartilage condition of 11 patients
who got the MRI evaluation before and after operation.
Their results indicate an overall improvement in cartilage
condition. Two patients who received arthroscopy com-
plained of transient numbness of the skin that was inner-
vated by a superficial peroneal nerve but improved with
no treatment 1 month after the operation. Subgroups of
patients were statistically evaluated to determine the influ-
ence of the operation on postoperative results; however,
no significant correlations were found between age, body
mass index (BMI), size, bone cyst, edema, sex, ankle lat-
eral instability, OSF lesion, clinical score, or MOCART
score.
On the preoperative MRI, three ankles (17.6 %) had
bone cysts, and four ankles (23.5 %) had an increasedsignal of subchondral bone. Two of three ankles with a
bone cyst were completely healed and one became 1/5
smaller than the preoperative size. Three of four ankles
with an edema of the subchondral bone were signifi-
cantly reduced; however, a new bone cyst developed
from one of them.
Discussion
The most important finding of the study is verifying the
effectiveness of atelocollagen and the mixture of atelo-
collagen and fibrin glue through an in vivo animal study
and the clinical outcome of an operation. Our hypoth-
esis that atelocollagen helps the regeneration of osteo-
chondral defect by acting as a scaffold held true. The
result of histology in animal studies indicates that atelo-
collagen acts as a scaffold at the defect and enhances tis-
sue regeneration by allowing bone marrow cells from
the microfracture and surrounding bone (as well as car-
tilage related cells) to adhere, proliferate, and maturate.
Fibrin glue with collagen transform liquid-type collagen
to a semi-solid state and can be used as a bioscaffold
Fig. 4 Microscopic view of repaired tissue 12 weeks after operation (hematoxylin/eosin). Cartilage defects in groups 1 and 4 were not adequately
filled with repaired tissue. Fibrocartilage tissue is also found in repaired tissue instead of normal hyaline cartilage. Defect completely filled with
repaired tissue in groups 2 and 3, and composed of normal hyaline cartilage. a, b Group 1. c, d Group 2. e, f Group 3. g, h Group 4. *right panel
is a magnified view of the yellow box in the left panel. HC hyaline cartilage, FC fibrocartilage
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numbers of spherically shaped chondrocytes, and ele-
vated mass retention after transplantation [19]. The use
of only fibrin glue causes incomplete healing; however,
the additional use of atelocollagen optimized healing.
Clinical reports indicate that microfracture is a widely
available, simple, and minimally invasive arthroscopic
technique associated with good results; however, increas-
ing age, a high BMI, and a large size (lesions >150 mm2)
produce poor outcomes [20]. Microfracture demon-
strates significantly better improvement than autologous
chondrocyte implantation for short-term reults; however,a longer follow-up shows that beneficial results are not
maintained despite equivalent clinical outcomes that in-
dicate a deterioration after microfracture [3, 21]. Studies
have been conducted for large-sized lesions and cases
that are predicted to have poor outcomes from micro-
fracture due to microfracture technique flaws such as
the instability of clots. To overcome these factors, vari-
ous enhanced microfracture techniques using scaffolds
or progenitor cells have been developed. A mixture of
atelocollagen and fibrin glue-enhanced microfracture
was recently developed; in addition, its efficacy was
reported in only one-knee and ankle-related article,
Fig. 5 Microscopic view of repaired tissue 12 weeks postoperatively (collagen type-II stain, safranin O stain). a Microfracture. b Microfracture +
atelocollagen. c Microfracture + atelocollagen + fibrin glue. d Microfracture + fibrin glue
Table 1 Histological scoring for in vivo rabbit study





Mixture of fibrin glue
and atelocollagen
2 weeks 21.3 ± 0.6 20.3 ± 0.6 20.0 ± 1.0 17.7 ± 1.5a,b
4 weeks 18.3 ± 0.6 20.0 ± 1.0 15.7 ± 2.1b 13.7 ± 0.6a,b
8 weeks 18.7 ± 0.6 19.7 ± 0.6 14.0 ± 1.0a,b 11.0 ± 1.0a,b,c
12 weeks 19.0 ± 2.0 14.7 ± 1.5a 12.0 ± 1.0a 9.7 ± 2.3a,b
n = 3
aP <0.05 compared to the control group at each week
bP <0.05 compared to the fibrin glue group at each week
cP <0.05 compared to the 3 % atelocollagen group at each week
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were treated with a similar technique that reported
the following: both good clinical and radiologic results
at the 2 year follow-up, an MRI with good filling of
the cartilage defects, and a biochemical MRI that sug-
gested hyaline-like repair tissue [22]. The difference be-
tween our techniques is that we only used suction drying
and Endo Peanut without a CO2 gas drying process. A
recent clinical report about the use of the atelocollagen-
fibrin-glue matrix was for the treatment of chondral
lesions of the talus, with a significant improvement of
VAS and AOFAS score at 6 months follow-up of 5 pa-
tients [23]. Our study had two times more patients and a
longer follow-up that more accurately evaluated the status
of osteochondral lesions by comparing post-operative and
Table 2 Demographic data of patients receiving operation for
enhanced microfracture of the talus
List No.
Male/female 10/7
Average patient age (years) 32.9 ± 12.8
Average BMI 25.2 ± 3.1 (24.9 ± 3.5/25.6 ± 2.9)
Average height (cm) 168 ± 6.8 (171 ± 4.5/163 ± 7.0)
Average weight (kg) 71.1 ± 10.2 (73.2 ± 22.8/68.1 ± 9.7)
Average size of osteochondral
lesion of talus
71.89 mm2 ± 35.0
Previous operative history 1 (lateral malleolar fracture)
Combined ankle problem
Chronic lateral ankle instability 10
Os foot subfibulare 2
Syndesmosis injury 1
S/P LM fracture (implant removal) 1






Subchondral bone cyst 3
Subchondral signal increase 5
History of trauma 1
BMI body mass index, S/P LM status of postoperative lat. malleolar fracture








2 III IIC 25
3 IIC
4 IIB
5 IIB IIB 45
6 IIB IIA 40
7 IV
8 III IIA 35
9 III I 40
10 IV IIA 45
11 IV
12 IV I 35
13 III
14 I I 45
15 III IIB 40
16 IIB I 45
17 I 0 50
MRI magnetic resonance imaging
Table 4 Comparison of modified Anderson’s MRI-based
classification score between preoperative state and 12-month
visit outcome
Stage Characteristics Initial MRI Follow-up MRI
(12-month visit)
Stage 0 Normal 0 (0 %) 1 (9.1 %)
Stage I Marrow oedema 2 (18.2 %) 4 (36.4 %)
Stage IIA Irregular subchondral
bone plate
0 (0 %) 3 (27.3 %)
Stage IIB Formation of subchondral
cyst
3 (27.3 %) 2 (18.2 %)
Stage IIC Incomplete separation of
fragment
0 (0 %) 1 (9.1 %)
Stage III Unattached, undisplaced
fragment with synovial
fluid around fragment
4 (36.4 %) 0 (0 %)
Stage IV Displaced fragment 2 (18.2 %) 0 (0 %)
Total number 11 11
MRI magnetic resonance imaging
Kim et al. Journal of Orthopaedic Surgery and Research  (2015) 10:82 Page 8 of 10pre-operative MRI. An autologous matrix-induced chon-
drogenesis (AMIC) and other techniques using various
kinds of scaffolds already produced satisfactory results
for chondral and osteochondral defects of the knee
joint prior to ankle [24–26]. However, limited reports
have been published on this novel technique, particu-
larly with the ankle compared to the knee joint. First,
the AMIC technique has been applied to both chon-
dral and osteochondral lesions of the ankle [27]. A simi-
lar novel technique was introduced by Zantop et al. [28].
In our study, all procedures were done easily using an
arthroscopic technique different from other techniques
performed by open capsulotomy and without donor site
morbidity. Different from the AMIC technique, an atelo-
collagen matrix was mixed with fibrin glue directly and
injected easily into the chondral defect.
Increasing age, high BMI, and large lesions are factors
that suggest a poor outcome for microfractures [20];
however, we saw no statistically negative effects from
these factors in this study. Another focus of ours is on
an atelocollagen and fibrin glue-enhanced microfracture
that can overcome a simple microfracture; however, the
demographics of our population (mean age, 32.9 years
and BMI, 25.2) do not fully reflect our focus. Only threepatients over 50 years old are included and scored a
mean AOFAS of 63.3 in pre-op that later improved to
93.3. Among them, two patients received a post-op MRI
and modified Anderson score that improved from IV,
IIB to I, I, respectively, with an average MOCART of 40.
The superiority of collagen-enhanced microfracture for
large osteochondral lesions and elderly patients was not
conclusively demonstrated. The biggest lesion in this
study was 156 mm2, and there were six patients with
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a mean AOFAS of 64 in pre-op that later improved to
86.7. From this result, we expect that further studies
with larger groups will confirm that atelocollagen and
fibrin glue-enhanced microfracture are effective for
elderly patients and large-size osteochondral lesions.
Subchondral bone conditions such as a bone cyst and
signal intensity of the repair tissue are concerns. Involve-
ment of the subchondral bone can be seen as sclerotic
changes, cyst formation, or avascular necrosis in large
talar lesions [29]. The integrity of the subchondral bone
plays an important role in the pathogenesis of ankle
osteochondral lesions (OCL); however, there is no con-
sensus on the treatment of these defects. Our technique
checked bone cysts through pre-op MRI and tried to
completely remove differentiated and debrided lesions
with a curette. Subchondral bone around the lesion was
decorticated and followed by a 6–7 mm-deep microfrac-
ture procedure. Good outcomes were obtained without a
bone graft; two of three were completely healed and the
other bone cyst was 1/5 times smaller but nearly filled
with repair tissue. In addition, 75 % (3/4) of patients
were cured of subchondral edema, but one patient de-
veloped an additional cyst below the microfracture site
with edema. The location of the bone cyst indicates it
may have been formed by leaked joint fluid from a tiny
gap below the bone bed where the microfracture was
performed. The clinical result was good with 87 points
at AOFAS. We believe that it is suitable to treat bone
cysts using our technique without a bone graft; however,
more data is needed to generalize the effectiveness of
this technique.
Microfracture predominantly produces fibrocartilage
[30], and many discussions remain about cartilage made
from autologous chondrocyte implantation [31–33]. How-
ever, the regenerated cartilage in our in vivo study was a
hyaline-like cartilage unlike the subsequent microfracture
and ACI. A biopsy could not be performed for ethical
reasons; however, good quality cartilage was observed
by radiological findings after collagen-enhanced micro-
fracture. Consequently, we expect good results from this
procedure.
The current study had several limitations. The clinical
study was carried in small scale without a control group
to effectively evaluate the efficacy of atelocollagen. An
on-going randomized controlled study with power calcu-
lation under the same protocols will supplement the lack
of data from the previous retrospective study. MRI data
weakened by losses in follow-up 35.2 % (6/17) may not
represent the whole group; however, most patients did
not want further evaluation tests because they were sat-
isfied with a mean AOFAS of 89.2. From this result, we
expect the mean MRI evaluation of the whole group to
improve. There could also be a minimal selection bias inthe evaluation of resolution of pain and disability be-
cause there were ten cases of instability and two cases of
Os subfibulare as company lesion in the object group.
Further mid-term and long-term follow-up must be
evaluated. In the in vivo study, a quantitative cell study
was not performed in the animal study even though the
histologic status of cartilage was evaluated; consequently,
additional evaluation is required for a quantifiable com-
parison. The duplication of human OLT is difficult to
make in animals since the intrinsic characteristic and
surrounding environment of cartilage are different and
may be the cause of different clinical study results in
clinical study. Therefore, a larger scale clinical study is
necessary to evaluate clinical efficacy.
This study is the first to report an in vivo histologic
animal study and the clinical results of radiographic
evaluation using MRI when atelocollagen was used for
treatment. This study is meaningful in revealing predict-
able results of atelocollagen for chondral lesion with the
number of subjects three times larger and the follow-up
period twice as long compared to previous clinical trials.
The mixture of atelocollagen and fibrin glue-enhanced
microfracture in this experiment is a simple one-step
procedure with no need to harvest cartilage, no risk of
contamination associated with an in vitro cell culture
procedure, and is more cost-effective. This technique
also showed a potential to overcome simple microfrac-
ture flaws and may be a good option for osteochondral
lesion treatment.
Conclusions
Good results were obtained in macroscopic and histo-
logical assessments of the outcomes of an in vivo animal
study. Microfracture with a mixture of atelocollagen and
fibrin glue was effective and safe to treat OCL of the talus.
Patients showed significant clinical improvement and sat-
isfaction postoperatively. Atelocollagen as a one-step pro-
cedure enables a satisfactory treatment of cartilage defects.
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